Every day of life with diabetes is a challenge. However, there is an elite group of people known as Medalists who’ve lived 50 years or more with Type 1 diabetes. We are joined by Dr. George King, Director of Research at Joslin Diabetes Center and Professor of Medicine at Harvard Medical School, to discuss the Joslin 50-Year Medalist Study. What does it take to be a 50-Year Medalists?
Posted in ADA, American Diabetes Association, c-peptide, diabetic complications, DKA, insulin, JDRF, podcasts, type 1 diabetes
Tagged boston, c-peptide, diabetes research, Joslin, Joslin 50 year medalist study, T1D, type 1 diabetes
Type 1 diabetes is caused by an autoimmune attack on the beta cells. Type 2 diabetes is caused by a metabolic response leading to insulin resistance. Both forms of diabetes result in high blood sugar but the cause of each form of diabetes is different. Jamie Perez and Jeanette Collier are the mothers of children with autoimmune diabetes. They speak with us about their mission to bring clarity to two different types of diabetes. Please review the petition to revise the names of Type 1 and Type 2 to reflect the nature of onset for each type of diabetes. It would benefit the safety, research efforts, and awareness of people living with either Type 1 or Type 2 diabetes.
Posted in ADA, American Diabetes Association, c-peptide, diabetic complications, DKA, insulin, JDRF, podcasts, prediabetes, type 1 diabetes, Type 2 diabetes
Tagged advocacy, diabetes, T1D, T2D
The JDRF is funding research efforts of ViaCyte to bring us closer to a T1D cure. ViaCyte is pioneering a combination product packaging stem cells that develop into insulin-producing cells. We speak with Dr. Julia Greenstein, Vice President for Cure Therapies at JDRF, to learn more about this promising T1D treatment.
Posted in c-peptide, insulin, JDRF, podcasts, type 1 diabetes
Tagged cure, insulin, islets, jdrf, stem cells, T1D, type 1 diabetes, ViaCyte
New research has shown that first-born children have less insulin sensitivity and higher daytime blood pressure than later-born children. We are joined by Wayne Cutfield, Professor of Paediatric Endocrinology, from the Liggins Institute, University of Auckland. He discusses the study and what can be done today to lower you risk for T2D tomorrow.
A biological cure for T1D is no longer a pie in the sky. It’s attainable and within our reach. We are joined by Dr. Camillo Ricordi, the Scientific Director at the Diabetes Research Institute, to discuss the BioHub. The DRI is pioneering a quantum leap in T1D treatment. Learn more about the BioHub, how it works, and when it may be available for people with T1D.
The t-slim is the newest insulin pump with intuitive and easy-to-use features. The t:slim was designed based on consumer needs. Tandem Diabetes Care is the developer of the t:slim pump. We speak with Linda Parks, National Director, Clinical Education at Tandem Diabetes Care, about the next generation insulin pump, available today.
The American Diabetes Association funded the DAISY Study to identify events that may trigger islet autoautibodies (IA). The presence of IA is a precursor that can lead to Type 1 diabetes. We are joined by a lead researcher in the DAISY Study, Janet Snell-Bergeon PhD, to discuss the findings and risks associated with the development of T1D.
Posted in ADA, podcasts, type 1 diabetes
Tagged barbra david center, barbra david center for dchilhood diabetes, Barbra Davis center, Barbra Davis center for childhood diabetes, cereal, colorado, cows milk, GAD, GAD65, gluten, gluten-free, IA2, IA2 IAA, IAA, insulin autoantibodies, milk, T1D risk, T1D risk factors, T1D risk T1D risk factors insulin autoantibodies GAD, type 1 diabetes, vaccinations, vaccines
Dr. Sanjoy Dutta, Senior Director of Treatment Research at JDRF, joins us to explain how the body senses low blood sugar. He clarifies why this sense becomes less sharp over time, the ability of the brain to adapt despite low blood sugar, and how the JDRF is researching to correct the dangerous condition of hypoglycemia unawareness.
Dr. Nicole Glaser is a pediatric endocrinologist at University of California at Davis and an American Diabetes Association funded researcher on Type 1 diabetes brain injury from DKA. Dr. Glaser joins us to speak about her pioneering research on brain injury that could result from DKA.
Posted in c-peptide, diabetic complications, DKA, podcasts, type 1 diabetes
Tagged amnesia, brain injury, contextual memory, diabetes, DKA, hypothalamus, T1D
Whether you’re new to diabetes or sick and tired of the disease, diabetes coaching may have something to offer. Diabetes coaching can help build stronger coping skills, cultivate healthier relationships with food, and make exercise a bigger priority in your life. We speak with Ginger Vieira, author, motivational speaker, and diabetes coach about the secrets to living well with diabetes.
Posted in diabetic complications, DKA, podcasts, prediabetes, type 1 diabetes, Type 2 diabetes
Tagged attitude, coping skills, diabetes science experiment, diet, emotional eating, exercise, health, physical exercise, wellbeing, wellness